We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$578B
AUM Growth
+$59.6B
Cap. Flow
+$35.2B
Cap. Flow %
6.08%
Top 10 Hldgs %
31.21%
Holding
15,826
New
1,745
Increased
6,428
Reduced
6,082
Closed
1,423

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$830M
2
UNH icon
UnitedHealth
UNH
+$769M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$691M
4
AMZN icon
Amazon
AMZN
+$654M
5
BAC icon
Bank of America
BAC
+$634M

Sector Composition

Rank Sector Weight
1 Healthcare 3.13%
2 Technology 2.97%
3 Financials 2.19%
4 Consumer Discretionary 2.09%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAPTW
14301
DELISTED
Captivision Inc Warrant
CAPTW
$352 ﹤0.01%
35,229
-2,480
-7% -$58
MCHX icon
14302
PUT
Marchex
MCHX
$77.5M
$350 ﹤0.01%
200
-1,800
-90% -$3.32K
CBIO
14303
PUT
Crescent Biopharma
CBIO
$610M
$349 ﹤0.01%
+14
New +$382
TXMD icon
14304
PUT
TherapeuticsMD
TXMD
$24.1M
$344 ﹤0.01%
400
-6,700
-94% -$9.43K
SVMHW
14305
DELISTED
SRIVARU Holding Limited Warrant
SVMHW
$329 ﹤0.01%
38,740
-1,010
-3% -$9
STIM icon
14306
PUT
Neuronetics
STIM
$211M
$322 ﹤0.01%
+200
New +$208
MKFG
14307
CALL
DELISTED
Markforged Holding Corporation
MKFG
$314 ﹤0.01%
100
-5,900
-98% -$24.8K
SLSR
14308
PUT
Solaris Resources
SLSR
$1.33B
$311 ﹤0.01%
+100
New +$270
GSIT icon
14309
CALL
GSI Technology
GSIT
$260M
$303 ﹤0.01%
100
-5,900
-98% -$18.6K
NVNO
14310
PUT
enVVeno Medical
NVNO
$7.5M
$302 ﹤0.01%
3
-146
-98% -$16.3K
PHLT
14311
PUT
DELISTED
Performant Healthcare Inc
PHLT
$302 ﹤0.01%
100
-21,500
-100% -$73.9K
IMUX icon
14312
Immunic
IMUX
$217M
$300 ﹤0.01%
30
-23,976
-100% -$302K
PXLW icon
14313
PUT
Pixelworks
PXLW
$42.3M
$292 ﹤0.01%
+33
New +$299
USIO icon
14314
PUT
Usio Inc
USIO
$71.5M
$292 ﹤0.01%
+200
New +$283
HYFM icon
14315
PUT
Hydrofarm Holdings
HYFM
$8.58M
$290 ﹤0.01%
+50
New +$327
VIRX
14316
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$290 ﹤0.01%
+1,800
New +$354
SKYE icon
14317
CALL
Skye Bioscience
SKYE
$19.3M
$283 ﹤0.01%
100
-8,000
-99% -$33.4K
HYMCL
14318
DELISTED
Hycroft Mining Holding Corp Warrants
HYMCL
$275 ﹤0.01%
18,997
-32,969
-63% -$729
REVBW icon
14319
Revelation Biosciences Warrant
REVBW
$9.41K
$268 ﹤0.01%
38,235
+8,835
+30% +$103
GNSS icon
14320
PUT
Genasys
GNSS
$77.4M
$260 ﹤0.01%
100
NLSPW
14321
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$246 ﹤0.01%
18,958
-668
-3% -$8
COEPW
14322
DELISTED
Coeptis Therapeutics Warrants
COEPW
$245 ﹤0.01%
11,145
-638
-5% -$15
AXDX
14323
CALL
DELISTED
Accelerate Diagnostics
AXDX
$240 ﹤0.01%
+200
New +$332
KPLTW
14324
DELISTED
Katapult Holdings Warrant
KPLTW
$232 ﹤0.01%
28,974
-3,232
-10% -$21
PTN
14325
CALL
Palatin Technologies
PTN
$16.8M
$222 ﹤0.01%
4
-226
-98% -$11.4K

Similar funds

Citadel Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.

  • Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
  • Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
  • Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
  • Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
  • Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.